Company / Share Buybacks
Labcorp Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$450.0M
FY2025
5-year range
$250.1M / $1.7B
FY2021-FY2025
Trend
+79.9%
vs FY2024
Sector context
#29 of 101
Health Care
What the data says
At $450M, Labcorp's share buybacks ranks #29 of 101 in the Health Care sector. Share Buybacks returned to growth in FY2025 after 3 years of decline, reaching $450M.
Based on SEC 10-K filings.
$450M in FY2025 with a 5-year CAGR of -8.5%.
Declined from $1.0B to $450M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Sector benchmark
#29 of 101 in Health CareTop 29% of 101This company $450.0M Sector average $570.7M
▼
-21.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.5%, indicating a declining trend.
- In FY2025, share buybacks increased 79.9% year-over-year.
- Ranks #29 out of 101 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $450.0M | +79.9% |
| FY2024 | $250.1M | -75.0% |
| FY2023 | $1.0B | -9.1% |
| FY2022 | $1.1B | -34.1% |
| FY2021 | $1.7B | +138.4% |
| FY2020 | $700.0M | +55.6% |
| FY2019 | $450.0M | -35.7% |
| FY2018 | $700.0M | +107.0% |
| FY2017 | $338.1M | +670.2% |
| FY2016 | $43.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026